公司资料
Benitec Biopharma 股价、新闻与催化剂
- 股票代码:
- BNTC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Australia and listed in the U
股票表现
11.36 USD (+2.90%)
收盘价
最后更新: 2026年9月17日
363M USD
市值
股价为何变动
截至 2026年9月17日，BNTC 上涨 2.90%，收于 $11.36。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Benitec Biopharma is a gene-silencing biotechnology company focused on DNA-directed RNA interference and genetic medicine. Its story is built around platform science that aims to durably suppress disease-causing genes.
所在地与行业分类
Benitec is headquartered in Australia and listed in the U.S. market. It sits in gene therapy and genetic medicine biotechnology.
商业模式特征
The business depends on translational validation, clinical milestones, and the ability to keep a narrow platform funded. Investors watch early data and strategic collaborations.
生物医药行业定位
Benitec occupies a gene-silencing niche within biotech. The stock is driven by whether the platform can prove durable and differentiated genetic medicine potential.
未来催化剂
- The next few months for Benitec Biopharma are centered on BB-301. The latest company update points to continued work around BB-301 and the next company-specific development update. If that progress holds, the program should stay on the radar through the rest of the quarter.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。